Advertisement

Lifepoint Health kicks off first-quarter earnings season to a rock start

By Dave Barkholz  |  April 29, 2016

LifePoint Health got the important first-quarter earnings season off to a rocky start Friday, posting a decline in earnings per share and leading hospital stocks to a down day on Wall Street. The system's shares never recovered from an early sell-off after the company announced Friday morning a...

Wayne State, DMC leaders agree to contract negotiating plan

By Jay Greene, Crain's Detroit Business  |  April 29, 2016

Top officials at Wayne State University and Detroit Medical Center have agreed to a new negotiating plan to move contract talks forward, Crain's Detroit Business has learned.

Valeant files overdue financial report, ending debt default

By Associated Press  |  April 29, 2016

Valeant Pharmaceuticals resolved its default on some of its $30 billion in debt by finally filing its long-overdue U.S. financial report for 2015 on Friday. The badly tarnished Canadian drugmaker also announced a slate of mostly new nominees for elections to its board in June.

Hospital chains banking on first-quarter earnings to boost stock prices

By Dave Barkholz  |  April 29, 2016

The Federal Reserve did its part this week to boost hospital stocks by again not raising interest rates. Now the investor-owned hospital companies will have to prove with their earnings whether it's safe for investors to give them another look.

Cardinal Health's drug sales boost overall revenue in Q3

By Michael Sandler  |  April 28, 2016

Cardinal Health reported a bump in revenue in its third quarter, driven by gains in the company's pharmaceutical segment. The Dublin, Ohio-based drug and medical products distributor reported $386 million in earnings during the last quarter, up 6% from last year.

SSM Health sheds coal company investments

SSM Health sheds coal company investments

By Bob Herman  |  April 28, 2016

SSM Health, a large Catholic hospital system, has fully divested its investments in companies that produce coal. It joins a growing coalition of healthcare organizations that view climate change as an immediate threat to public health.

Abbott to spend $19.3B to buy St. Jude Medical

By Associated Press  |  April 28, 2016

Abbott Laboratories will spend $19.3 billion to buy St. Jude Medical in a cash-stock deal that aims to strengthen the medical-device maker's share of the market for cardiovascular care.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.